Diadema Partners LP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Diadema Partners LP reported 86 stock positions worth $242.2 million. Its top holding was Bridgebio Pharma Inc. (bbio 1.75 03/01/31) at 7.7% of the portfolio, followed by Viking Therapeutics (VKTX, 7.1%) and United Therapeutics (UTHR, 6.7%). Compared with Q4 2025, it opened 43 new positions, sold out of 30, added to 26 and reduced 17. The biggest buy was a new position in Bridgebio Pharma Inc. (bbio 1.75 03/01/31) and the biggest sale an exit from Regeneron Pharmaceuticals (REGN).
- Most Recent 13F
- Q2 2026
- Location
- MORRISTOWN, NJ
- CIK
- 0002026172
- Portfolio Value
- $242.2M (Q1 2026)
- SEC Filing
- 0001892688-26-000076 ↗ filed May 15, 2026
Holdings Value
Holdings 86 stocks · $242.2M
| BRIDGEBIO PHARMA INC (BBIO 1.75 03/01/31) | 7.67% | 250,000 | $18.6M | New |
| VKTX Viking Therapeutics Inc. | 7.06% | 525,181 | $17.1M | Add +55.9% |
| UTHR United Therapeutics Corp. | 6.69% | 27,303 | $16.2M | Add +173.0% |
| JNJ Johnson & Johnson | 5.43% | 53,771 | $13.1M | Reduce -19.1% |
| COGT Cogent Biosciences Inc. | 5.13% | 322,764 | $12.4M | Add +144.8% |
| JAZZ Jazz Pharmaceuticals PLC | 4.27% | 54,755 | $10.4M | New |
| TERN Terns Pharmaceuticals Inc. | 3.96% | 181,752 | $9.6M | Reduce -47.5% |
| BMRN Biomarin Pharmaceutical Inc. | 3.46% | 148,229 | $8.4M | Add +1.3% |
| ABVX Abivax SA-ADR | 3.39% | 75,944 | $8.2M | Add +0.4% |
| RVMD Revolution Medicines Inc. | 3.25% | 80,872 | $7.9M | Add +118.5% |
| KOD Kodiak Sciences Inc. | 3.04% | 192,962 | $7.4M | New |
| INCY Incyte Corp. | 3.03% | 78,029 | $7.3M | New |
| TGTX TG Therapeutics Inc. | 2.84% | 206,928 | $6.9M | Add +67.8% |
| BBIO Bridgebio Pharma Inc. | 2.62% | 85,311 | $6.3M | Add +21.9% |
| IMCR Immunocore Holdings PLC-ADR | 2.41% | 193,189 | $5.8M | Add +174.8% |
| LLY Eli Lilly & Co. | 2.28% | 6,000 | $5.5M | Add +200.0% |
| ABBV Abbvie Inc. | 2.16% | 24,058 | $5.2M | New |
| RCUS Arcus Biosciences Inc. | 2.12% | 238,142 | $5.1M | New |
| CRBP Corbus Pharmaceuticals Holdi | 1.71% | 439,957 | $4.1M | New |
| CRVS Corvus Pharmaceuticals Inc. | 1.48% | 244,811 | $3.6M | New |
| ZYME Zymeworks Inc. | 1.47% | 142,132 | $3.6M | New |
| GPCR Structure Therapeutics Inc. | 1.44% | 72,234 | $3.5M | New |
| GLUE Monte Rosa Therapeutics Inc. | 1.27% | 187,307 | $3.1M | Add +200.8% |
| TENX Tenax Therapeutics Inc. | 1.19% | 179,738 | $2.9M | Reduce -26.1% |
| HRMY Harmony Biosciences Holdings | 1.07% | 92,864 | $2.6M | Add +1138.2% |
| CAPR Capricor Therapeutics Inc. | 0.99% | 78,851 | $2.4M | Reduce -50.1% |
| EYPT Eyepoint Inc. | 0.95% | 178,545 | $2.3M | New |
| BCYC Bicycle Therapeutics PLC-ADR | 0.91% | 476,424 | $2.2M | New |
| INDV Indivior Pharmaceuticals Inc. | 0.90% | 71,376 | $2.2M | Add +312.1% |
| CLYM Climb Bio Inc. | 0.81% | 286,126 | $2.0M | New |
| IVA Inventiva SA - ADR | 0.80% | 352,399 | $1.9M | Add +5.4% |
| STTK Shattuck Labs Inc. | 0.78% | 293,664 | $1.9M | New |
| TARS Tarsus Pharmaceuticals Inc. | 0.75% | 25,942 | $1.8M | New |
| ALKS Alkermes PLC | 0.73% | 50,000 | $1.8M | New |
| MGNX Macrogenics Inc. | 0.72% | 600,000 | $1.7M | New |
| VRTX Vertex Pharmaceuticals Inc. | 0.71% | 3,840 | $1.7M | Reduce -61.6% |
| VYGR Voyager Therapeutics Inc. | 0.68% | 423,642 | $1.6M | New |
| PCVX Vaxcyte Inc. | 0.60% | 25,071 | $1.5M | Add +9.1% |
| RLMD Relmada Therapeutics Inc. | 0.58% | 200,842 | $1.4M | Reduce -48.4% |
| BIOA Bioage Labs Inc. | 0.43% | 60,000 | $1.0M | Reduce -77.9% |
| INO Inovio Pharmaceuticals Inc. | 0.40% | 562,665 | $979K | Add +5.4% |
| AYTU Aytu Biopharma Inc. | 0.40% | 353,077 | $964K | Add +15.5% |
| EQ Equillium Inc. | 0.36% | 433,844 | $868K | Add +24.9% |
| DNTH Dianthus Therapeutics Inc. | 0.35% | 10,000 | $839K | New |
| PHVS Pharvaris NV | 0.34% | 29,321 | $828K | New |
| ENTA Enanta Pharmaceuticals Inc. | 0.34% | 64,952 | $820K | Reduce -0.3% |
| REPL Replimune Group Inc. | 0.32% | 100,660 | $770K | Reduce -56.4% |
| XERS Xeris Biopharma Holdings Inc. | 0.32% | 132,746 | $770K | Reduce -22.2% |
| LRMR Larimar Therapeutics Inc. | 0.31% | 166,637 | $750K | New |
| ANNX Annexon Inc. | 0.30% | 132,916 | $736K | Reduce -62.0% |
| RARE Ultragenyx Pharmaceutical Inc. | 0.30% | 35,144 | $736K | New |
| MLYS Mineralys Therapeutics Inc. | 0.29% | 26,347 | $714K | Add +5.4% |
| UNCY Unicycive Therapeutics Inc. | 0.29% | 106,083 | $698K | New |
| SPRB Spruce Biosciences Inc. | 0.27% | 10,000 | $654K | New |
| PHAT Phathom Pharmaceuticals Inc. | 0.25% | 54,650 | $607K | New |
| CELC Celcuity Inc. | 0.25% | 5,314 | $607K | New |
| CNTB Connect Biopharma Holdings L | 0.22% | 200,690 | $526K | New |
| NVO Novo-Nordisk A/S-Spons ADR | 0.21% | 14,577 | $521K | New |
| PTHS Pelthos Therapeutics Inc. | 0.21% | 24,773 | $520K | Reduce -0.9% |
| QURE Uniqure NV | 0.21% | 31,200 | $510K | Reduce -30.7% |
| MNKD Mannkind Corp. | 0.19% | 186,603 | $457K | Reduce -38.2% |
| MAZE Maze Therapeutics Inc. | 0.18% | 15,000 | $448K | New |
| URGN Urogen Pharma Ltd. | 0.17% | 23,155 | $416K | Add +6.2% |
| CORT Corcept Therapeutics Inc. | 0.17% | 10,000 | $403K | Reduce -89.7% |
| LPCN Lipocine Inc. | 0.17% | 50,000 | $400K | Reduce -80.8% |
| FHTX Foghorn Therapeutics Inc. | 0.16% | 79,944 | $382K | Add +161.0% |
| GHRS GH Research PLC | 0.16% | 26,836 | $377K | New |
| OCGN Ocugen Inc. | 0.15% | 200,000 | $362K | New |
| PRQR Proqr Therapeutics NV | 0.12% | 180,083 | $292K | Add +7.5% |
| EPRX Eupraxia Pharmaceuticals Inc. | 0.12% | 40,000 | $290K | New |
| PEPG Pepgen Inc. | 0.11% | 150,925 | $267K | New |
| TRVI Trevi Therapeutics Inc. | 0.11% | 21,663 | $258K | Reduce -77.7% |
| PGEN Precigen Inc. | 0.09% | 55,293 | $214K | New |
| UPB Upstream Bio Inc. | 0.08% | 21,609 | $194K | Add +5.4% |
| CMPS Compass Pathways PLC | 0.07% | 31,885 | $176K | New |
| PASG Passage Bio Inc. | 0.06% | 19,530 | $153K | New |
| TLPH Talphera Inc. | 0.05% | 153,563 | $115K | Add +12.2% |
| RCKT Rocket Pharmaceuticals Inc. | 0.05% | 30,579 | $109K | New |
| MNPR Monopar Therapeutics Inc. | 0.04% | 1,630 | $89K | New |
| VTGN Vistagen Therapeutics Inc. | 0.02% | 105,428 | $60K | Add +5.4% |
| RNA Atrium Therapeutics Inc. | 0.01% | 2,512 | $34K | New |
| CUE Cue Biopharma Inc. | 0.01% | 131,997 | $30K | New |
| ENTX Entera Bio Ltd. | 0.01% | 23,260 | $26K | New |
| PRTCY Puretech Health PLC - ADR | 0.00% | 7,924 | $11K | Add +6.5% |
| ELVN Enliven Therapeutics Inc. | 0.00% | 245 | $10K | New |
| SEPN Septerna Inc. | 0.00% | 202 | $5K | New |
Options reported separately and not counted above: VRTX calls ($41.6M), LQDA calls ($25.0M), UTHR calls ($23.8M), VKTX calls ($21.5M), CAPR puts ($19.0M), APGE calls ($18.7M), CYTK puts ($13.2M), RVMD puts ($12.2M), MRK puts ($12.0M), UTHR puts ($11.9M), ABVX puts ($11.1M), ABVX calls ($11.1M), and 46 more.
Portfolio Sells Q4 2025 → Q1 2026
| REGN Regeneron Pharmaceuticals | Sold out | 0.00% | −4.73 |
| TERN Terns Pharmaceuticals Inc. | Reduce -47.5% | 3.96% | −4.37 |
| JNJ Johnson & Johnson | Reduce -19.1% | 5.43% | −2.76 |
| ANIP Ani Pharmaceuticals Inc. | Sold out | 0.00% | −2.51 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -61.6% | 0.71% | −1.99 |
| CORT Corcept Therapeutics Inc. | Reduce -89.7% | 0.17% | −1.85 |
| CAPR Capricor Therapeutics Inc. | Reduce -50.1% | 0.99% | −1.73 |
| BIOA Bioage Labs Inc. | Reduce -77.9% | 0.43% | −1.70 |
| IRWD Ironwood Pharmaceuticals Inc. | Sold out | 0.00% | −1.37 |
| CNTA Centessa Pharmaceuticals Ltd. | Sold out | 0.00% | −1.34 |
| ALNY Alnylam Pharmaceuticals Inc. | Sold out | 0.00% | −1.26 |
| PTGX Protagonist Therapeutics Inc. | Sold out | 0.00% | −1.18 |
| LPCN Lipocine Inc. | Reduce -80.8% | 0.17% | −1.08 |
| VTYX Ventyx Biosciences Inc. | Sold out | 0.00% | −1.08 |
| REPL Replimune Group Inc. | Reduce -56.4% | 0.32% | −1.02 |
| BCRX Biocryst Pharmaceuticals Inc. | Sold out | 0.00% | −0.89 |
| ARDX Ardelyx Inc. | Sold out | 0.00% | −0.88 |
| ASND Ascendis Pharma A/S | Sold out | 0.00% | −0.87 |
| MNKD Mannkind Corp. | Reduce -38.2% | 0.19% | −0.83 |
| RIGL Rigel Pharmaceuticals Inc. | Sold out | 0.00% | −0.77 |
| ANNX Annexon Inc. | Reduce -62.0% | 0.30% | −0.74 |
| SLNO Soleno Therapeutics Inc. | Sold out | 0.00% | −0.74 |
| PCRX Pacira Biosciences Inc. | Sold out | 0.00% | −0.74 |
| MPLT Maplight Therapeutics Inc. | Sold out | 0.00% | −0.67 |
| TRVI Trevi Therapeutics Inc. | Reduce -77.7% | 0.11% | −0.62 |
| PRTA Prothena Corp. PLC | Sold out | 0.00% | −0.61 |
| TENX Tenax Therapeutics Inc. | Reduce -26.1% | 1.19% | −0.58 |
| DSGN Design Therapeutics Inc. | Sold out | 0.00% | −0.56 |
| RLMD Relmada Therapeutics Inc. | Reduce -48.4% | 0.58% | −0.54 |
| XERS Xeris Biopharma Holdings Inc. | Reduce -22.2% | 0.32% | −0.48 |
| LQDA Liquidia Corp. | Sold out | 0.00% | −0.45 |
| EWTX Edgewise Therapeutics Inc. | Sold out | 0.00% | −0.44 |
| QURE Uniqure NV | Reduce -30.7% | 0.21% | −0.43 |
| VRDN Viridian Therapeutics Inc. | Sold out | 0.00% | −0.39 |
| VIR Vir Biotechnology Inc. | Sold out | 0.00% | −0.36 |
| LGND Ligand Pharmaceuticals | Sold out | 0.00% | −0.34 |
| STOK Stoke Therapeutics Inc. | Sold out | 0.00% | −0.32 |
| IMNM Immunome Inc. | Sold out | 0.00% | −0.29 |
| ENTA Enanta Pharmaceuticals Inc. | Reduce -0.3% | 0.34% | −0.27 |
| PTHS Pelthos Therapeutics Inc. | Reduce -0.9% | 0.21% | −0.25 |
| PALI Palisade Bio Inc. | Sold out | 0.00% | −0.23 |
| AARD Aardvark Therapeutics Inc. | Sold out | 0.00% | −0.12 |
| NEUP Neuphoria Therapeutics Inc. | Sold out | 0.00% | −0.12 |
| PLRX Pliant Therapeutics Inc. | Sold out | 0.00% | −0.11 |
| ONC Beone Medicines Ltd.-ADR | Sold out | 0.00% | −0.10 |
| INBX Inhibrx Biosciences Inc. | Sold out | 0.00% | −0.06 |
| EDSA Edesa Biotech Inc. | Sold out | 0.00% | −0.05 |
Portfolio Buys Q4 2025 → Q1 2026
| BRIDGEBIO PHARMA INC (BBIO 1.75 03/01/31) | New | 7.67% | +7.67 |
| JAZZ Jazz Pharmaceuticals PLC | New | 4.27% | +4.27 |
| UTHR United Therapeutics Corp. | Add +173.0% | 6.69% | +3.78 |
| KOD Kodiak Sciences Inc. | New | 3.04% | +3.04 |
| INCY Incyte Corp. | New | 3.03% | +3.03 |
| COGT Cogent Biosciences Inc. | Add +144.8% | 5.13% | +2.34 |
| ABBV Abbvie Inc. | New | 2.16% | +2.16 |
| RCUS Arcus Biosciences Inc. | New | 2.12% | +2.12 |
| CRBP Corbus Pharmaceuticals Holdi | New | 1.71% | +1.71 |
| RVMD Revolution Medicines Inc. | Add +118.5% | 3.25% | +1.49 |
| CRVS Corvus Pharmaceuticals Inc. | New | 1.48% | +1.48 |
| ZYME Zymeworks Inc. | New | 1.47% | +1.47 |
| GPCR Structure Therapeutics Inc. | New | 1.44% | +1.44 |
| LLY Eli Lilly & Co. | Add +200.0% | 2.28% | +1.00 |
| IMCR Immunocore Holdings PLC-ADR | Add +174.8% | 2.41% | +0.95 |
| EYPT Eyepoint Inc. | New | 0.95% | +0.95 |
| BCYC Bicycle Therapeutics PLC-ADR | New | 0.91% | +0.91 |
| HRMY Harmony Biosciences Holdings | Add +1138.2% | 1.07% | +0.91 |
| CLYM Climb Bio Inc. | New | 0.81% | +0.81 |
| STTK Shattuck Labs Inc. | New | 0.78% | +0.78 |
| TARS Tarsus Pharmaceuticals Inc. | New | 0.75% | +0.75 |
| ALKS Alkermes PLC | New | 0.73% | +0.73 |
| MGNX Macrogenics Inc. | New | 0.72% | +0.72 |
| GLUE Monte Rosa Therapeutics Inc. | Add +200.8% | 1.27% | +0.69 |
| VYGR Voyager Therapeutics Inc. | New | 0.68% | +0.68 |
| TGTX TG Therapeutics Inc. | Add +67.8% | 2.84% | +0.65 |
| INDV Indivior Pharmaceuticals Inc. | Add +312.1% | 0.90% | +0.53 |
| DNTH Dianthus Therapeutics Inc. | New | 0.35% | +0.35 |
| PHVS Pharvaris NV | New | 0.34% | +0.34 |
| LRMR Larimar Therapeutics Inc. | New | 0.31% | +0.31 |
| RARE Ultragenyx Pharmaceutical Inc. | New | 0.30% | +0.30 |
| UNCY Unicycive Therapeutics Inc. | New | 0.29% | +0.29 |
| SPRB Spruce Biosciences Inc. | New | 0.27% | +0.27 |
| PHAT Phathom Pharmaceuticals Inc. | New | 0.25% | +0.25 |
| CELC Celcuity Inc. | New | 0.25% | +0.25 |
| CNTB Connect Biopharma Holdings L | New | 0.22% | +0.22 |
| NVO Novo-Nordisk A/S-Spons ADR | New | 0.21% | +0.21 |
| MAZE Maze Therapeutics Inc. | New | 0.18% | +0.18 |
| GHRS GH Research PLC | New | 0.16% | +0.16 |
| OCGN Ocugen Inc. | New | 0.15% | +0.15 |
| EPRX Eupraxia Pharmaceuticals Inc. | New | 0.12% | +0.12 |
| PEPG Pepgen Inc. | New | 0.11% | +0.11 |
| PGEN Precigen Inc. | New | 0.09% | +0.09 |
| CMPS Compass Pathways PLC | New | 0.07% | +0.07 |
| PASG Passage Bio Inc. | New | 0.06% | +0.06 |
| FHTX Foghorn Therapeutics Inc. | Add +161.0% | 0.16% | +0.06 |
| RCKT Rocket Pharmaceuticals Inc. | New | 0.05% | +0.05 |
| EQ Equillium Inc. | Add +24.9% | 0.36% | +0.04 |
| MNPR Monopar Therapeutics Inc. | New | 0.04% | +0.04 |
| RNA Atrium Therapeutics Inc. | New | 0.01% | +0.01 |
Options Activity Q4 2025 → Q1 2026
| VRTX Vertex Pharmaceuticals Inc. | call | Add +5.4% | 93,100 | $41.6M |
| XBI SS SPDR S&P Biotech ETF | put | Sold out | 250,000 | $30.5Mbefore exit |
| PRAX Praxis Precision Medicines I | put | Sold out | 100,600 | $29.7Mbefore exit |
| LQDA Liquidia Corp. | call | New | 662,100 | $25.0M |
| UTHR United Therapeutics Corp. | call | New | 40,200 | $23.8M |
| RNAM Avidity Biosciences Inc. | call | Sold out | 328,000 | $23.7Mbefore exit |
| VKTX Viking Therapeutics Inc. | call | Reduce -4.3% | 659,200 | $21.5M |
| CAPR Capricor Therapeutics Inc. | put | Add +211.7% | 623,400 | $19.0M |
| APGE Apogee Therapeutics Inc. | call | Add +5.4% | 222,500 | $18.7M |
| QQQ Invesco QQQ Trust Series 1 | put | Sold out | 30,000 | $18.4Mbefore exit |
| JAZZ Jazz Pharmaceuticals PLC | call | Sold out | 105,300 | $17.9Mbefore exit |
| BBIO Bridgebio Pharma Inc. | put | Sold out | 200,000 | $15.3Mbefore exit |
| GPCR Structure Therapeutics Inc. | call | Sold out | 191,700 | $13.3Mbefore exit |
| CYTK Cytokinetics Inc. | put | New | 200,000 | $13.2M |
| RVMD Revolution Medicines Inc. | put | New | 125,500 | $12.2M |
| MRK Merck & Co. Inc. | put | New | 100,000 | $12.0M |
| UTHR United Therapeutics Corp. | put | New | 20,000 | $11.9M |
| VKTX Viking Therapeutics Inc. | put | Sold out | 316,700 | $11.1Mbefore exit |
| ABVX Abivax SA-ADR | put | New | 100,000 | $11.1M |
| ABVX Abivax SA-ADR | call | New | 100,000 | $11.1M |
| BBIO Bridgebio Pharma Inc. | call | Sold out | 139,600 | $10.7Mbefore exit |
| JNJ Johnson & Johnson | call | Sold out | 50,000 | $10.3Mbefore exit |
| CAPR Capricor Therapeutics Inc. | call | Add +5.4% | 329,300 | $10.0M |
| INCY Incyte Corp. | put | Add +5.4% | 105,400 | $9.9M |
| KOD Kodiak Sciences Inc. | put | New | 246,900 | $9.4M |
| ROIV Roivant Sciences Ltd. | put | Add +5.4% | 335,800 | $9.3M |
| INSM Insmed Inc. | call | Sold out | 52,800 | $9.2Mbefore exit |
| IONS Ionis Pharmaceuticals Inc. | call | Sold out | 106,200 | $8.4Mbefore exit |
| MRNA Moderna Inc. | put | New | 159,400 | $8.1M |
| INDV Indivior Pharmaceuticals Inc. | call | Sold out | 220,300 | $7.9Mbefore exit |
| EWTX Edgewise Therapeutics Inc. | call | New | 212,500 | $6.7M |
| OCUL Ocular Therapeutix Inc. | call | Sold out | 545,200 | $6.6Mbefore exit |
| CORT Corcept Therapeutics Inc. | call | New | 158,500 | $6.4M |
| ZYME Zymeworks Inc. | call | Sold out | 240,600 | $6.3Mbefore exit |
| GPCR Structure Therapeutics Inc. | put | New | 127,500 | $6.1M |
| CRSP Crispr Therapeutics AG | call | Reduce -5.7% | 106,300 | $5.1M |
| QURE Uniqure NV | put | Reduce -0.9% | 299,000 | $4.9M |
| CORT Corcept Therapeutics Inc. | put | Sold out | 134,800 | $4.7Mbefore exit |
| QURE Uniqure NV | call | New | 250,000 | $4.1M |
| REGN Regeneron Pharmaceuticals | call | Sold out | 5,000 | $3.9Mbefore exit |
| REPL Replimune Group Inc. | put | New | 459,900 | $3.5M |
| CYTK Cytokinetics Inc. | call | New | 50,000 | $3.3M |
| MNKD Mannkind Corp. | call | Sold out | 552,300 | $3.1Mbefore exit |
| PCVX Vaxcyte Inc. | call | New | 53,100 | $3.1M |
| RXRX Recursion Pharmaceuticals-A | call | Sold out | 741,900 | $3.0Mbefore exit |
| TGTX TG Therapeutics Inc. | put | Sold out | 100,000 | $3.0Mbefore exit |
| NTLA Intellia Therapeutics Inc. | put | Sold out | 316,900 | $2.8Mbefore exit |
| GOSS Gossamer Bio Inc. | call | Sold out | 877,100 | $2.7Mbefore exit |
| BHVN Biohaven Ltd. | call | Add +58.5% | 317,000 | $2.7M |
| ABUS Arbutus Biopharma Corp. | call | Sold out | 548,600 | $2.6Mbefore exit |
Showing the first 50 of 103.
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 77 | $264.6M | UTHR, RVMD, ABVX, COGT, BMRN |
| Q1 2026 | 86 | $242.2M | BRIDGEBIO PHARMA INC (BBIO 1.75 03/01/31), VKTX, UTHR, JNJ, COGT |
| Q4 2025 | 73 | $167.9M | TERN, JNJ, VKTX, ABVX, BMRN |
| Q3 2025 | 59 | $143.6M | REGN, SLNO, BMRN, PCVX, INDV |
| Q2 2025 | 46 | $160.8M | SLNO, AMGN, TGTX, NBIX, LLY |
| Q1 2025 | 43 | $125.1M | REGN, LLY, JAZZ, TGTX, ARGX |
| Q4 2024 | 54 | $88.7M | BMY, ABBV, TEVA, BPMC, RYTM |